Citius Oncology, Inc. (CTOR) vs MindWalk Holdings Corp. (HYFT)

A side-by-side comparison of Citius Oncology, Inc. and MindWalk Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CTOR vs HYFT

growth of $100 · dividends reinvested · last 2y
CTOR -92.4% (-72.4%/yr)HYFT +75.3% (+32.4%/yr)HYFT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$8$175
CTOR HYFT

CTOR vs HYFT: by the numbers

  • •CTOR is the larger company ($79M vs $69M market cap).
  • •Both run net losses; HYFT's is the smaller (-105.29% vs -648.32% net margin).

Metrics side by side

Valuation

MetricCTORHYFT
Forward P/E8.50N/A
P/S ratio11.125.89
P/B ratio1.9614.01

Profitability

MetricCTORHYFT
Gross margin0.00%60.78%
Operating margin0.00%-96.01%
Net margin-648.32%-105.29%
ROE-114.06%-250.39%
ROIC-88.72%-153.46%

Growth (annualized)

MetricCTORHYFT
Revenue CAGR (5Y)N/A-4.48%
Total return CAGR (5Y)N/A-23.93%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.